PHARMACOLOGICAL INHIBITION OF CD38 ENHANCES THE ANTIBODY-DEPENDENT TUMOR-KILLING EFFECT OF NATURAL KILLER (NK) CELLS ON BREAST CARCINOMA CELLS.

Németh Péterdr. Polgár Zsuzsannadr. Virág László2023-06-222023-06-222023-06https://hdl.handle.net/2437/355893PHARMACOLOGICAL INHIBITION OF CD38 ENHANCES THE ANTIBODY-DEPENDENT TUMOR-KILLING EFFECT OF NATURAL KILLER (NK) CELLS ON BREAST CARCINOMA CELLS.